secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001437749-25-021278
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed stockholders elect seven directors and approve 2025 equity plan at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected; John Alam received 3,923,241 votes for, 21,554 withheld.
- Ratification of RSM US LLP as auditor approved: 5,571,505 for, 25,008 against, 13,724 abstain.
- Advisory vote on 2024 executive compensation approved with 3,891,229 for, 33,195 against, 20,371 abstain.
- CervoMed 2025 Equity Incentive Plan approved: 3,798,568 for, 137,758 against, 8,469 abstain.
- Approximately 5.61 million shares voted, representing 64.5% of outstanding shares; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774925021278/0001437749-25-021278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774925021278/crvo20250625_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer